OCGN
OcugenANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
OCGN vs peer average
90/100
OCGN vs. peer average (A vs. C)
Grade spread
B 3 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
DMAC is the first available peer comparator.
DiaMedica is a usable small-cap biotech comparison for catalyst and capital-markets sensitivity, though it is not a direct ophthalmology comparable.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OCGN
Ocugen
DMAC
DiaMedica Therapeutics
Grade
A
F
Momentum
92
9
Value
41
42
Sentiment
68
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs DMAC
OCGN / DMAC
Grade Position
Above peers
OCGN vs. peer average (A vs. C)
90/100
Momentum
92
OCGNValue
41
DMACSentiment
68
OCGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OCGN
DMAC is the first peer returned for this comparison set.